600 patients66,869 observations120 daysLIVE

Patient P-01631

Synthetic patientNBL-101 · Day 112 · 65–74 · F · baseline S14Open companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
63%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+26
  • Inflammatory activity+11
  • Nutritional resilience-7
  • Toxicity-5
  • Treatment adherence+4

What helped?

No interventions yet.

    LIFE OS recommendation
    Clinician Review CR-01
    77%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 100% showed improvement
    • median effect visible after 5 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Autonomic recovery 65
      • WearableResting HR 75 bpm
      • Wearable1,223 steps/day
      • WearableShort sleep window
    • Inflammatory signalling 60
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 29 ms, trending down
    • Mucosal barrier integrity 10
      • WearableSleep 5.9 h, below personal baseline
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 3.8 · butyrate capacity 51/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    33 ms
    Sleep
    6.9 h
    Steps
    3,657
    Resting HR
    71 bpm
    Daily log: GI score 36, nutritional resilience 59, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0146158%S1961
    P-0162956%S1966
    P-0164350%S1765
    P-0181750%S1467
    P-0144649%S0353
    P-0149949%S0265
    P-0180449%S19AD-05improved61
    P-0143048%S05CR-01improved54
    P-0150848%S1868
    P-0156948%S0458
    P-0167048%S1159
    P-0176748%S14DT-01no change63